Week 47 · 2026Friday, 20 November 2026
Economy

Uzbekistan and EGIS Discuss Expansion of Pharmaceutical Cooperation

Director of the Agency Abdulla Azizov discussed with EGIS the expansion of the company's operations in Uzbekistan, investments, and new projects.

19 Nov, 16:02Read in Russian

The meeting addressed the development of EGIS's activities in the Uzbek market and cooperation between Uzbekistan and Hungary in the pharmaceutical sector.

The parties also discussed drug production, the introduction of modern technologies, and the expansion of the product range. Additionally, participants separately considered the application of the company's international experience.

EGIS is among the pharmaceutical manufacturers of Central and Eastern Europe. Its products are available in 105 countries, and its portfolio includes 656 medicinal products. For the 2024/2025 financial year, the company's sales amounted to 773.3 million euros, with an additional 56.6 million euros allocated to research and development.